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1. Introduction 
1.1 The burden of osteoporotic fractures 
Osteoporosis is a disorder of low bone mass and micro-architectural deterioration in bone, 
resulting in increased bone fragility and susceptibility to fractures even after minimal or 
inadequate trauma [Anonymous, Consensus conference, 1993]. On statistical grounds, more 
than 50% of postmenopausal women, and approximately 30% of men over the age of 60 
years will suffer at least one minimal trauma fracture during their remaining lifetime [Kanis 
et al. 2000]. However, any osteoporotic fracture predisposes to further fractures, significant 
morbidity, and premature death. There is a 2-3 fold increase in the risk of repeat fractures 
after a first minimal trauma fracture. This is true for both men and women in all age 
categories [Langsetmo et al. 2009]. In the year 2000, there were about 8.9 million fractures 
worldwide [Johnell et al. 2006], of which 1.6 million were hip fractures. The number of hip 
fractures is expected to increase worldwide to 6.26 million by 2050 in the context of an 
ageing population, and longer life expectancy in the developing world [Sambrook P, Cooper 
C. 2006]. In Australia, the annual number of fractures is projected to increase by 250%, from 
83,238 in 1996 to 207,657 fractures in 2051 as a result of the ageing population. Hip fractures 
are expected to quadruple over the same period of time [Sanders et al. 1999]. There is 
significant economic burden associated with minimal trauma fractures. In the USA the cost 
of minimal trauma fractures was estimated at US $17 billion in 2005, with the annual cost 
predicted to increase by 50% in 2025 [Burge et al. 2007]. In Australia the cost of fragility 
fractures was AU$ 7.4 billion in 2001 [Sambrook et al. 2002].  
1.2 The treatment gap in osteoporosis 
Despite the availability of advanced medical care and medications that reduce the risk of re-
fracture by 30–90% [Giangregorio et al., 2006], the majority of patients with incident 
osteoporotic fractures are neither investigated nor treated for their underlying condition. 
This is referred to as the ‘treatment gap in osteoporosis’, which has been extensively 
documented in the international literature [Bliuc et al., 2005; Panneman et al., 2004; Shibli-
Rahhal et al., 2011]. A systematic review [Giangregorio et al. 2006] revealed that following a 
minimal trauma fracture the median rate of bone mineral density (BMD) testing was as low 
as 10%, as was the initiation of treatment (Figs. 1, 2). 
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Fig. 1. The diagnostic gap: Low rate of investigations after a minimal trauma fracture. 
(Reproduced from Giangregorio et al., 2006, with permission.) 
A thorough understanding of the factors contributing to the care gap in osteoporosis is 
pivotal to finding effective solutions. Generally speaking, significant deficits exist on three 
different levels: patient, doctor, and system level. On a patient and doctor level, a lack of 
awareness and understanding that a minimal trauma fracture should prompt a thorough 
evaluation for osteoporosis has been well documented [The Burden of Brittle Bones, 2007]. 
Patients may be reluctant to be evaluated due to perceived medication side effects, time 
constraints, costs, and language barriers. A desire to avoid polypharmacy may also 
contribute to the reluctance of elderly patients and their carers to initiate treatment. Doctors 
may have the misconception that the current treatments available for osteoporosis are 
ineffective or fraught with side effects, or they may not have the resources (e.g. for bone 
mineral density testing) or time to evaluate patients for osteoporosis, especially in an acute 
hospital setting. On a systems level, fragmentation of care further contributes to the “care 
gap”, in that no single care provider (primary care physician, orthopaedic surgeon, 
specialist physician, or primary care physician) takes responsibility for osteoporosis 
management. Furthermore, a lack of funding for osteoporosis may be a consequence of low 
priority of osteoporosis in the public mind. For instance, osteoporosis has to compete for 
funding with diseases such as breast cancer and leukaemia which have more ‘prestige’ and 
therefore lobbying power, probably because they are associated with death at a younger 
age. According to the National Institutes of Health in the US [http://report.nih.gov/ 
rcdc/categories/], estimated funding for breast cancer research for the 2011 financial year 
was quadruple that for osteoporosis, despite a higher incidence of osteoporosis. That is, 
12.5% of women in the US will develop breast cancer during their lifetime, whereas 50% of 
women will suffer from a minimal trauma fracture after the age of 60 years. 
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Fig. 2. The therapeutic gap: Low rate of osteoporosis treatment after a minimal trauma fracture. 
Key: BP = bisphosphonate, SERM = Selective Estrogen Receptor Modulator, HRT = Hormone 
Replacement Therapy. (Reproduced from Giangregorio et al., 2006, with permission.) 
2. Fracture liaison services 
2.1 Bridging the gap in osteoporosis care through fracture liaison services 
The acute presentation of a patient with a minimal trauma fracture to a health care facility 
(usually an emergency department) is an easily identifiable clinical event. Care of these 
patients is then transferred to an orthopaedic service, either in an inpatient or an outpatient 
setting. This process represents a unique window of opportunity to identify, investigate and 
appropriately treat patients with osteoporosis [Gallacher, 2005]. Thus, over the last 10 years 
several groups across the world, including Australia, Canada, Europe and the USA have 
attempted to address the osteoporosis care gap via the development and clinical 
implementation of what is now generally known as “Fracture Liaison Services” (FLS). 
However, the published literature on FLS, while substantial and often of good quality, is 
characterized by enormous heterogeneity in the methods of patient identification, patient 
capture, and intensity of intervention. Thus, there is significant variation in the type of 
studies, patient characteristics, methodology and criteria of patient identification. The extent 
of engagement of the service in the investigation and treatment of the patient also varies 
significantly, together with outcomes in relation to bone mineral density (BMD) testing, 
treatment initiation, adherence, and re-fracture rates. This chapter will review the existing 
literature on FLS to provide a coherent overview of their methodology and outcomes.  
2.2 Models of Care based upon intervention intensity 
The spectrum of possible interventions prompted by a patient presenting to hospital with a 
minimal trauma fracture can be summarized as follows: 
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i. Provision of specific “osteoporosis protocols” to staff at inpatient wards, orthopaedic 
fracture clinics and emergency departments; 
ii. Education of patients through letter (information sheet), or direct communication either 
‘face-to-face’ or via telephone; 
iii. Alerting the Primary Care Physician (PCP) of the need to evaluate and treat their 
patient for osteoporosis via direct communication, letter, or email; 
iv. Assessment of clinical risk factors for osteoporosis; 
v. Offering BMD testing (osteodensitometry); 
vi. Investigation for secondary causes of osteoporosis; 
vii. Initiating treatment (both non-pharmacological and pharmacological); 
viii. Monitoring with regular follow-up, using a dedicated database to evaluate effectiveness 
of intervention. 
Depending on the model of care implemented at any given site, the actual intervention can 
range from a simple, education-based model with high patient capture and turnover to 
more complex models involving most or all components listed above. More complex, 
intensive models typically incorporate patient education and risk assessment, with on-site 
bone densitometry testing, as well as treatment initiation. In these complex models of care it 
is often the fracture liaison co-coordinator who plays a pivotal role in orchestrating and co-
ordinating care, after the minimal trauma fracture. 
Given the heterogeneity in models of care and their reporting of outcomes, the following 
classification of FLS from ‘type A’ to ‘type D’ models of care, based upon the type and 
intensity of the intervention has been suggested (Table 1). ‘Type E’ model of care is a 
category unrelated to intervention intensity, representing inpatient intervention only:  
 
Model of Care Description 
A Identification, Assessment (risk factors, pathology testing, BMD), 
Treatment initiation 
B Identification, Assessment, Treatment recommendation only 
C Education of patient and Primary Care Physician 
D Education of patient only 
E Inpatient specialist consultation 
Table 1. Categorical types of FLS according to Model of Care 
This categorization of intervention types is graded from A through to D, with A 
representing the most intensive, all-encompassing intervention. Although each model of 
care is unique, there are significant variations in details of the intervention, and reporting 
of outcomes between each study. It is also important to note that health care 
environments and resources differ with countries, leading to the development of unique 
models of care. 
2.3 ‘Type A’ models of care 
Since 2000, there have been thirteen studies published describing a ‘type A’ model of care, 
heralding from Australia (four studies – Kuo et al., 2007; Vaile et al., 2007; Giles et al., 2010; 
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Lih et al., 2011), US (three studies – Edwards et al., 2005; Dell et al., 2008; Navarro et al., 
2011), Canada (three studies – Bogoch et al., 2006; Majumdar et al., 2007 & 2011; Morrish et 
al., 2009) and Europe (two studies – Clunie et al., 2008; Boudou et al., 2011). A further two 
studies focused on the cost analysis of individual FLS (Sander et al., 2008; Cooper et al., 
2011).  
These clinical studies are unique in describing a co-ordinated model of care through which 
patients are identified, assessed and treated following a minimal trauma fracture as part of 
an all-encompassing service. Assessment includes evaluation of clinical risk factors for 
osteoporosis, a bone mineral density scan, radiographic or other imaging as required, and 
various pathology tests to exclude secondary causes of osteoporosis. This assessment is then 
followed by the initiation of appropriate non-pharmacological and pharmacological 
interventions. An example of a classical ‘type A’ model of care is the Concord Hospital FLS 
(Figure 3). Table 2 illustrates the summary of outcomes for ‘Type A’ model of care. For a 
more analytical evaluation of the cited studies see Appendix A. 
 
 
 
Identify Patients
In-patients Discharges from ED
Orthopaedics Geriatrics
MTF Screening Clinic
History/ Examination
Lab Screen, BMD, X-ray
Treatment and f/u
Transfers
Non-Frail Frail
Fracture Clinic LMO Specialist
 
 
 
Fig. 3. An example of the structure of a ‘Type A’ FLS. Key: MTF = Minimal Trauma Fracture;  
f/u = follow-up; LMO=Local Medical Officer or primary care physician 
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Table 2. ‘Type A’ Model of Care Fracture Liaison Services – Summary of Outcomes;  
Key: The first % figure in each cell represents the intervention group result and the second 
% figure represents the control group. ‘v’ =versus. F=female, M=male, BMD/Rx=BMD 
testing and/or treatment rates; RRR= relative risk reduction, BMD=BMD testing rates; 
Rx=treatment rates; See Appendix A for further details. 
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‘Type A’ model of care fracture liaison services – Summary of outcomes 
The twelve studies evaluating a ‘type A’ model of care reviewed here varied greatly in 
regards to study design, ranging from randomised controlled trials to simple cross-sectional 
analyses. All except one study [Boudou et al., 2011] evaluated male and female patients, 
with information on racial background being reported in 3 out of 11 studies [Majumdar et 
al., 2007 & 2011; Navarro et al., 2011]. The number of patients ranged from 46 to 620,000, but 
most studies included between 200 to 400 subjects. Most studies included all fracture types. 
So far, only two FLS were analysed in regards to their cost-effectiveness but in both cases 
cost-effectiveness of the service was clearly established. 
In terms of outcomes, all ‘type A’ FLS resulted in increased assessment, testing and 
treatment rates. In the four studies that included valid control groups, the average rate of 
BMD testing increased from 40.5% in the controls to 80.5% in the intervention groups 
[Majumdar et al., 2007 & 2011; Morrish et al., 2009 & Lih et al., 2011]. In the same studies, the 
average rate of anti-osteoporosis treatment initiation rose from 22% in the control groups to 
58% in the intervention groups. Re-fracture rates were reported in only four studies. Lih and 
colleagues (2011) reported a significant improvement in re-fracture rate from 19.7% in the 
control group to 4.1% in the intervention group. Dell and colleagues (2008) reported a 
relative risk reduction of 37.2% for hip fractures, using historical data for comparison. 
Boudou and colleagues (2011) reported an 11.4% re-fracture rate after a mean follow-up 
period of 27.4 months, while the study by Morrish et al. (2009) was underpowered to 
demonstrate any significant changes in re-fracture rates after one year of follow-up.  
A ‘type A’ intervention represents the most intensive and costly model of care, where 
patients are identified, assessed and treated for their osteoporosis after minimal trauma 
fracture. Central to the success of this model is the Fracture Liaison Co-ordinator (FLC), who 
orchestrates the identification, assessment and treatment of eligible patients. Thus, the 
barriers of patient education, primary care physician inertia and lack of a single care 
provider are addressed in one all-encompassing service. As expected, most ‘type A’ fracture 
liaison services differ by region due to the fact that they are embedded within different 
health care systems. This difference is primarily apparent if one compares the United States 
with Australia. While successful FLS have been developed in Australia, all of the services 
are based upon individual initiatives with no systemic support by the Area Health Service. 
As a result, patient numbers are relatively small. In contrast, the US system exemplified by 
the Kaiser Permanente group has the advantage of integrated, electronic health care delivery 
network, enabling the FLS to serve larger numbers of patients. In addition, there is a process 
of continual feedback to stimulate improvements in care over time. Non-electronic based 
intervention models have the disadvantage of being more labour-intensive. Overall, the 
critical component of these services is streamlining the transition from acute fracture care to 
osteoporosis care, targeted at reducing the risk of future fractures.  
As a general observation, most ‘type A’ fracture liaison services identified patients from a 
number of sources, including emergency departments, outpatients clinics and inpatient 
wards. The setting in which assessment, treatment and follow-up occurs is generally on an 
outpatient basis, which requires patients to be ambulatory and not institutionalised. This is 
reflected by a comparatively “young” mean age of 68 years in ‘type A’ studies, as well as a 
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predilection for the recruitment of patients with non-hip fractures. Thus the care of patients 
with minimal trauma fractures can be conceptualised as having two arms – one arm for the 
frail elderly who constitute most patients with hip fractures, and the other arm for the 
younger, more ambulatory patients who tend to have non-hip fractures. Although it is 
important to treat the frail elderly patient for osteoporosis after a minimal trauma fracture, 
these patients are streamlined to the realm of the geriatricians who need to prioritise 
osteoporosis treatment in the context of multiple competing co-morbidities. On the other 
hand, the ‘type A’ fracture liaison service is ideally suited to younger patients with minimal 
trauma fractures because it is easier for them to attend outpatient clinics. In addition, 
identifying osteoporosis and treating osteoporosis early will reduce the risk of future 
fractures for those with a likely life expectancy beyond twenty years. Thus, the short term 
expenditure of a health care system on a ‘type A’ FLS, will have substantial health and 
economic benefits for the population as a whole, in any country or region of the world. 
2.4 ‘Type B’ models of care  
‘Type B’ models of intervention are slightly less intensive compared to ‘type A’ models of 
care in that treatment initiation is the responsibility of the primary care physician. That is, 
‘type B’ interventions identify and assess patients with a minimal trauma fracture, then 
make treatment recommendations to the primary care physician. There have been eleven 
studies describing a ‘type B’ intervention, including New Zealand (one study – Sidwell et 
al., 2004) and Canada (one study – Morrish et al., 2009), the United States (two studies – 
Cuddihy et al., 2004 & Johnson et al., 2005), the United Kingdom (four studies – 
Charalambous et al., 2002; McLellan et al., 2003; Langridge et al., 2007 & McLellan et al., 
2011) and the Netherlands (three studies – Chevalley et al., 2002; Astrand et al., 2006 & 
Huntjens et al., 2010). Table 3 illustrates the summary of outcomes for ‘Type B’ model of 
care. For a more analytical evaluation of the cited studies see Appendix B. 
‘Type B’ model of care fracture liaison services – Summary of outcomes  
We have identified eleven publications describing a ‘Type B’ intervention. One of these was 
a review of five different fracture liaison services in the Netherlands. Thus there are a total 
of 15 ‘Type B’ models of care described from New Zealand (n= 1), the United States (n =2), 
Canada (n = 1), and Europe (n= 11). Study types varied between randomised controlled / 
case control studies (n= 1 each), ‘before and after’ studies (n= 4) and cross-sectional analyses 
(n= 9). The average proportion of females was 72%, with one study recruiting only female 
patients, and another including 96% males. Racial background was reported in only one 
study, at 86% white Caucasian. The number of subjects varied from 96 to 11,096 with a 
median number of subjects per study of 934. The mean age across all studies was 68 years 
and the wrist was the most frequent site of fracture. This is in keeping with the fact that 
most patients were identified in an outpatient setting, and patients with dementia, or frail 
patients were excluded. All services apart from two [Sidwell et al., 2004 & Charalambous et 
al., 2002] utilized a fracture liaison co-ordinator.  
In terms of outcomes, the overall rate of BMD testing and/or treatment reported in two 
studies was about 76% [Charalambous et al., 2002 & McLellan et al., 2003]. In four studies 
with control group outcomes, the average rate of bone mineral density testing in controls 
was 12.5%, and 57.5% in the intervention groups [McLellan et al., 2003; Cuddihy et al., 2004; 
Sidwell et al., 2004 & Johnson et al., 2005]. In three cross-sectional studies, the average rate of 
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BMD testing was 68% [Chevalley et al., 2002; Astrand et al., 2006 & McLellan et al., 2011]. In 
three studies with control group outcomes for treatment rates, the average rate of initiation 
of anti-osteoporosis medications in controls was 9%, compared to 35% in the intervention 
groups [Sidwell et al., 2004; Johnson et al., 2005 & McLellan et al., 2011]. Cuddihy et al., 2004 
and Johnson et al., 2005 reported adherence rates at six months, of 7.5% in the control group 
versus 24.5% in the intervention group. The Glasgow Fracture Liaison Service, reported re-
fractures rates of 5.1% at 3.5 years follow-up, and 12% at 8 years follow-up [McLellan et al., 
2011]. In the same study, the Glasgow service was been shown to be cost-effective. 
Taken together, ‘Type B’ interventions appear to be nearly as effective as a ‘Type A’ 
interventions if implemented in the right setting. On the other hand, as shown by Majumdar 
and Morrish in a randomised controlled trial, there is an incremental benefit in BMD testing 
and treatment rates with ‘Type A’ versus ‘Type B’ models of care. Another interesting point 
is the high number of patients identified with this form of intervention – that is, a high 
turnover rate, which does not necessarily translate to anti-fracture benefits in the long term. 
This is illustrated by comparing the re-fracture rate of 4.1% (over 4 years) in the ‘Type A’ 
Concord Hospital service, with the re-fracture rate of 12% over 4 years in the ‘Type B’ 
Glasgow service. While both services differ in some aspects they are similar enough to allow 
a comparison of fracture outcomes. Therefore, the lower re-fracture rate in ‘Type A’ services 
may be related to greater attention given to patient follow-up and compliance within the 
service itself, rather than relying on external follow-up by the PCP. ‘Type B’ services seem to 
be most effective if there is a good rapport and communication between the primary care 
physician and the fracture liaison service. 
2.5 ‘Type C’ models of care 
‘Type C’ models of care are characterised by a less intensive intervention, compared to ‘A’ 
and ‘B’ designs. Once patients are identified after their minimal trauma fracture they receive 
education regarding osteoporosis in general, risk factors for osteoporosis, lifestyle advice 
(including falls prevention) and the need for further assessment and treatment. The second 
component of this model of care involves engaging and alerting the primary care physician 
regarding the minimal trauma fracture, and the need for further assessment and treatment 
to reduce the risk of further fractures. Communication with patient or primary care 
physician is performed either ‘face-to-face’, via personalised letter, or a telephone call. No 
further assessment is performed with respect to bone mineral density testing or specific 
treatment for osteoporosis by the FLS. 
Table 4 summarises the outcomes from a total of twelve studies describing a ‘type C’ model 
of care: one from Australia, six from the United States, and five from Canada. For a more 
analytical evaluation of the cited studies see Appendix C. 
‘Type C’ Model of care fracture liaison services – Summary of outcomes  
There are twelve published studies describing ‘type C’ interventions, including four 
randomised controlled trials [Gardner et al., 2005; Feldstein et al., 2006; Solomon et al., 2007; 
Majumdar et al., 2008], four ‘before and after’ analyses [Inderjeeth et al., 2010; Harrington et 
al., 2005 (two studies); Hawker et al., 2003], two prospective controlled trials [Ashe et al., 
2004; Majumdar et al., 2004], one cross sectional study [Skedros, 2004], and one cluster 
randomised trial [Cranney et al., 2008]. Patients were identified from wards, outpatient 
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departments and the emergency departments by a fracture liaison nurse in all but four 
studies, in which existing staff were utilized, such as orthopaedic surgeons [Cranney et al., 
2008; Hawker et al., 2003; Skedros, 2004; Inderjeeth et al., 2010]. To determine outcomes, 
most patients were followed-up at six months after the intervention, apart from two studies 
which involved 10 and 18 month follow-up periods [Solomon et al., 2007 & Harrington et 
al., 2005 respectively]. The average rate of BMD testing and/or treatment for osteoporosis 
was reported in seven studies [Gardner et al., 2005; Feldstein et al., 2006; Harrington et al., 
2005; Solomon et al., 2007; Majumdar et al., 2004 & 2008], with a rate in the control group of 
11.7 %( range 5%-21%), compared to 39.2% (range 14%-71%) in the intervention group. This 
translated to a 27.5% improvement with the intervention. Derived from six studies 
[Inderjeeth et al., 2010; Majumdar et al., 2004 & 2008; Ashe et al., 2004; Hawker et al., 2003; 
Cranney et al., 2008], the average rate of BMD testing was 18% (range 3%-28%) in the control 
group and 59% (range 43%-92%) in the intervention group. This represents a risk difference 
of 41% with the intervention. Amongst the five studies reporting on anti-osteoporosis 
treatment [Inderjeeth et al., 2010; Feldstein et al., 2006; Majumdar et al., 2004 & 2008; 
Hawker et al., 2003], the average rate was 7.6% (range 5%-10%) in the control group, and 
24.4% (range 11%-40%) in the intervention group. This translates to a 16.8% absolute 
improvement with intervention ‘type C’. 
The provision of information to patients and physicians was the key component of all ‘type 
C’ services. Despite this, there was still significant variability in the results with different 
studies. For instance the study by Solomon et al. (2007) only improved BMD testing and/or 
treatment by 4% (baseline of 10%). There may be a number of factors contributing to this 
poor result, such as the non-patient specific nature of the educational intervention for the 
primary care physicians in this study, whereby a list of patients was provided during a visit 
to the primary care physician by a pharmacist, who then provided general information 
about osteoporosis to the physician. Secondly, patient education took the form of an 
automated phone call to the patient, which is probably not as effective as personal “one-on-
one” contact over the phone or face-to-face. Thirdly, there may have been resistance from 
physicians to the intervention, as pharmacists may not have as much impact on practice as a 
“respected opinion leader”. This is in contrast to other studies which provided information 
to primary care physicians with the endorsement of a “respected opinion leader”. 
2.6 ‘Type D’ models of care 
‘Type D’ interventions represent a model of care in which patients receive specific osteo-
porosis education following a minimal trauma fracture. Patient education can take the form 
of a patient-specific letter, educational pamphlet, video, or personal communication to the 
patient via a telephone or ‘face-to-face’ interaction. Table 5 summarises the major outcomes 
reported in the three publications describing a ‘Type D’ model of care. For a more analytical 
evaluation of the cited studies see Appendix D. 
‘Type D’ model of care fracture liaison services – Summary of outcomes 
As illustrated in Table 5, patient education alone has little or no impact on rates of treatment 
initiation, despite an increase in the rate of BMD testing. Thus, it is unlikely that this form of 
intervention has any impact, unless combined with other components such assessment and 
treatment for osteoporosis.  
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Table 4. ‘Type C’ Model of Care Fracture Liaison Services – Summary of Outcomes.  
Key: The first % figure in each cell represents the intervention group result and the second % figure 
represents the control group. ‘v’ =versus. BMD/Rx=BMD testing and/or treatment rates; 
BMD=BMD testing rates; Rx=treatment rates; Y = Yes. See Appendix C for further details. 
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Table 5. ‘Type D’ Model of Care Fracture Liaison Services – Summary of Outcomes; Key: The 
first % figure in each cell represents the intervention group result and the second % figure represents 
the control group. ‘v’ =versus. BMD/Rx=BMD testing and/or treatment rates; BMD=BMD testing 
rates; Rx=treatment rates; see Appendix D for further details. 
2.7 ‘Type E’ models of care 
‘Type E’ interventions are limited to inpatient specialist consultations. This intervention 
does not include any outpatient component and is the most heterogenous model as 
inpatient consultations vary significantly in the degree of intervention at each site. Table 6 
illustrates the summary of outcomes for ‘Type E’ model of care. For a more analytical 
evaluation of the cited studies see Appendix E. 
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Country Study Study Type BMD/Rx BMD Rx R
Chong et al. 2008 Cross Sectional NA NA NA
Jones et al. 2005 Before & After NA NA 24% vs 5%
Streeten et al. 2006 Cross Sectional NA 66% 68% vs 3%
Jachna et al. 2003 Cross Sectional NA NA No significant impact
Kamel et al. 2000 Cross Sectional NA 3%
<10% (93% medical 
consultant)
EU - UK Wallace et al. 2011 Cross Sectional NA NA 90.5% vs 60.5%
Australia
United 
States
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‘Type E’ model of care fracture liaison services - Summary of outcomes 
Taken together, inpatient protocols together with ortho-geriatric and fracture liaison 
services improved treatment outcomes. However, inpatient physician consultation alone 
appeared to be ineffective. This is likely due to the fact that a specific osteoporosis 
consultation was not asked for in these studies. Summary statistics were not performed due 
to marked variability in the reporting of outcomes, making interpretation relative to other 
models of care less reliable. It is important to bear in mind that most of the studies 
published on fracture liaison services excluded frail, demented patients, often living in 
assisted accommodation. A separate assessment pathway is required, as their needs are very 
different from those who are still living at home. Perhaps a greater focus needs to be placed 
on falls prevention strategies in this sub-group. 
3. Conclusions 
In this chapter, an attempt has been made to collate, compare and discuss the methodology 
and outcomes of different types of fracture liaison services around the world. Comparisons 
between models, and even within the same intervention model are generally difficult due to 
a lack of standardised outcome measures. Nevertheless, Table 7 represents a summary of 
relevant outcome data (rates of BMD testing, rates of treatment initiation), categorised 
according to the model of care. Figure 4 illustrates the same outcome measures without 
correction against controls, which are often not valid (e.g. historical controls), or not 
reported. It is clear from this summary that the effectiveness of a fracture liaison service is 
related to the intensity of the intervention. Thus, ‘type A’ models of care are more effective 
than ‘type B’ models of care, and ‘type B’ models of care produce better outcomes than ‘type 
C’, or ‘D’ models of care. This relationship is also evident from a number of randomised 
controlled trials [Gardner et al., 2005; Bliuc et al., 2006; Feldstein et al., 2006; Majumdar et al., 
2007 & 2008; Solomon et al., 2007; Morrish et al., 2009]. Clearly, the specific health care 
system in which a FLS is embedded is of pivotal importance. For example, a ‘type B’ model 
of care has been shown to be extremely effective in the UK due to the strong structural 
integration between primary care physicians and public hospitals. As would be expected, 
educational interventions alone (type C and D interventions) were less effective than types 
A and B interventions. An educational intervention system still had some limited benefits, 
and may be an option in resource poor areas.  
Intervention Type BMD (%) Rx (%)
A 85 (58‐100) 57 (45‐90)
B 62 (44‐93) 42 (27‐63)
C 59 (43‐92) 27 (11‐40)
D 35 (15‐51) 16 (6‐29)  
Table 7. Outcome measures according to intervention model of care, including the ranges of 
outcome rates (%) across studies.  
A further factor which is likely to have a significant impact on the effectiveness of any 
intervention is the length of time between the fracture and the intervention. For example, 
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treatment rates at six months with the same ‘type C’ intervention was 22% if the 
intervention occurred immediately after the fracture [Majumdar et al., 2008], compared to 
11% if the same intervention occurred one year after the fracture [Majumdar et al, 2011]. 
Perhaps the short period of pain associated with the fracture provides a ‘window of 
opportunity’ to instigate behavioural change in the patient.  
A major deficit in the published literature on models of post-fracture care is the inconsistent 
reporting of results. This covers a spectrum of outcomes such as the identification rate of 
potentially eligible patients, the length of time between fracture and FLS evaluation, the 
extent of risk factor evaluation, the assessment for secondary causes for osteoporosis, the 
rate of BMD testing, the rate of treatment, adherence to anti-osteoporosis therapy, the 
definition of the term “appropriate care”, re-fracture rates, and formal cost-effectiveness 
evaluations. All of these measures would be important for quality assurance and to 
benchmark performance. Thus, guidelines on reporting outcomes may be of benefit in the 
future. 
 
Fig. 4. Relationship between intervention intensity and outcomes. The dotted line  
represents the proportion of patients on treatment without any intervention.  
Key: Rx = anti-osteoporosis treatment; BMD = bone mineral density testing. 
Not only is their heterogeneity in outcomes, but also the very definition of a minimal 
trauma. Although the vast majority of studies define it as a fall from standing height or less, 
one study defined minimal trauma as the impact from a fall less than one metre in height 
[Bessette et al. 2011[. It is questionable if a fall from two or three steps, or inversion of the 
ankle should be defined as minimal trauma.  
The vast majority of studies (91%) included both males and females, with the mean 
proportion of females in each study of 72%. Four studies (9%) included females only. Many 
studies confirm the well-known gender disparity in the evaluation and treatment of 
osteoporosis [Bogoch et al., 2006; Cuddihy et al., 2004; Dell et al 2008; Diamond and 
Lindenberg 2002; Kuo et al., 2007; Navarro et al., 2011].  
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The under-recognition of osteoporosis in men is illustrated by Cuddihy and colleagues, who 
noted amongst those who had a prior fracture, none of the men had a diagnosis of 
osteoporosis, whereas 79% of women did. Similarly, Bogoch and co-workers noticed that 
baseline osteoporosis treatment rates were lower in men (15.5%) than in women (39%). Kuo 
and colleagues also found the baseline osteoporosis management rates were lower in men 
(9%) compared with women (34%).  
Furthermore, after institution of the Healthy Bones Program, the Kaiser Permanente group 
reported a significant gender disparity, with a higher treatment rate amongst women 
(92.1%) compared to men (75.2%) [Navarro et al. 2011]. In the same study, amongst those 
who sustained a further hip fracture, 73.5% of women and 30.7% of men were on 
osteoporosis treatment at the time of the fracture. With the institution of the Healthy Bones 
Program, Dell et al. (2008) reported an increase in the proportion of all BMD scans 
performed for men from 7.2% in 2002, to 14.5% in 2006. The proportion of all osteoporosis 
therapy dispensed for men went from 8% (2002) to 10% (2006), which is much lower than 
expected from the gender distribution in the studies (i.e., 25% were men).  
The factors contributing to the gender disparity include men being less proactive with their 
health than women, due to lack of interest or awareness. Physicians may be more 
complacent with men due to a misperception that osteoporosis only affects women. Bliuc 
and colleagues (2006) found that men were less likely than women to respond to an 
information based intervention by going to their PCP for osteoporosis assessment. Amongst 
those who did see their PCP, men were less likely to have anti-resorptives recommended, 
indicating a physician-related barrier to treatment. Diamond and Lindenberg also reported 
lower treatment uptake rates amongst men who sustained a minimal trauma fracture and 
were found to have an osteoporotic range BMD T-score. 
These studies indicate that the gender disparity needs to be addressed on different levels: 
patient, health care professional, and system level. Awareness of the gender disparity in 
recognition and treatment of osteoporosis may help clinicians target this group more 
effectively.  
Ethnicity was only reported in five of forty two studies. Despite documented racial 
disparities in osteoporosis management in the United States [Wei et al., 2003; Epstein et al., 
2010], it is reassuring to see an absence of racial disparity in the Kaiser Permanente system 
of care [Navarro et al. 2011]. 
Treatment rates may vary between health networks and countries due to different diagnos-
tic and treatment thresholds. For example, in the South Glasgow service, patients with hip 
fractures were treated without a prior BMD scan, whereas in the West Glasgow service a 
BMD study was routinely preformed in all patients and pharmacotherapy was initiated if 
the T-score was less than -2.0 SD. This threshold, however, differs from that of other centres 
(e.g. Majumdar et al., 2007: T-score of less than -1.5 SD). In the UK studies, only oral 
bisphosphonates were initiated, mostly due to cost considerations. Those patients who 
could not tolerate or receive oral bisphosphonates were treated with calcium and vitamin D 
only, a strategy which would certainly differ between countries.  
Treatment rates are still suboptimal, even in ‘type A’ services. In order to improve capture 
rates, fracture liaison services will need to utilize integrated electronic health system databases. 
There is no doubt that there is a paucity of data on re-fracture rates, adherence, and cost-
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effectiveness of intensive models of care, although initial results are promising. Attempts 
should be made at collaboration between centres, especially in fragmented health care 
networks within countries. Unfortunately, there is a paucity of data on FLS in the majority of 
the world’s population. That is, the populations of the US, Canada, Australia, New Zealand 
and Europe only constitute 17% of the world’s population. We need to ensure that treatment 
disparities between regions, genders, as well as race, are addressed. Therefore, although 
fracture liaison services have contributed significantly towards closing the care gap in 
osteoporosis management in patients after a minimal trauma fracture, there is room for 
significant improvements in post-fracture management of patients with osteoporosis.  
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5. Appendices 
5.1 Appendix A 
5.1.1 ‘Type A’ fracture liaison services in Australia 
There have been four publications from Australia describing a ‘Type A’ intervention [Kuo et 
al., 2007; Vaile et al., 2007; Giles et al., 2010; Lih et al., 2011]. Individual hospital Fracture 
Liaison Services have grown over the last decade, out of individuals “championing” the 
cause of patients after a minimal trauma fracture. Each hospital has tailored their approach 
according to their resources and experience.  
Australian residents fall under the umbrella of Medicare, a comprehensive health care 
system whereby free public hospital care is provided. Medicare Australia also funds the 
Pharmaceutical Benefits Scheme (PBS), whereby a comprehensive list of pharmaceuticals are 
subsidized. This system provides an ideal environment for fracture liaison services because 
medical practitioner consultation, osteodensitometry, and pathology testing are performed 
at no expense to the patient. A comprehensive list of specific anti-osteoporosis therapy is 
subsidized by the PBS, thus allowing patients to commence (and continue) treatment at 
minimal expense. Notably, calcium and vitamin D supplementation is not subsidized under 
this scheme. 
Despite universal health care coverage in Australia, there is limited integration of health 
care information and collaboration between hospitals, probably due to historical precedent 
in funding structure of individual hospitals. Therefore various FLS have developed 
independently in individual hospitals, leading to smaller numbers of patients in each study 
(hundreds), in contrast to the Kaiser Permanente group in the US (thousands of patients) 
which is characterized by an integrated electronic medical record system spanning wide 
geographic areas.  
The New South Wales (NSW) government is currently attempting to integrate and 
standardize post-fracture care in NSW, through the Agency for Clinical Innovation (ACI). 
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The ACI is focused on an agenda to develop FLS in all hospitals across NSW to address the 
care gap in osteoporosis. Ideally, this system would allow integration of all data in a central 
database to help benchmark performance. 
Study types and patient characteristics 
There have been two ‘before and after’ type studies [Kuo et al., 2007; Vaille et al., 2007], one 
cross-sectional study [Giles et al., 2010], and one prospective controlled study [Lih et al., 
2011]. All studies were from Eastern New South Wales. Three studies had control groups: in 
in the study by Lih and colleagues (2011), the control group was concurrent. That is, the 
control group was derived from eligible patients who presented to hospital with a minimal 
trauma fracture but for various reasons were not seen by the FLS. The other two studies 
reported historical control groups, which therefore provide less robust outcome data [Kuo et 
al., 2007; Vaile et al., 2007].  
All studies recruited male and female patients, with the proportion of females varying from 
71% to 79%. Race or ethnicity was not described in any of the four studies but given the 
demographics of Eastern New South Wales, it is likely that the majority of patients were of 
Caucasian ethnicity. The numbers of patients identified by each FLS ranged from 155 to 
2049. All four studies included patients who sustained symptomatic fractures at any site 
although three studies excluded skull fractures [Kuo et al., 2007; Giles e al., 2010; Lih et al., 
2011], and Kuo et al. (2007) excluded fractures of fingers and toes, whilst Lih and colleagues 
excluded vertebral fractures. In the three studies reporting on fracture sites, the proportion 
of patients with wrist fractures varied from 22-45%. The lower age limit was 50 years in two 
studies [Vaile et al., 2007; Giles et al., 2010], 45 years [Lih et al, 2011], and 20 years [Kuo et al, 
2007]. The mean age of patients varied from 60 years to 75 years. The reason for the older 
demographic in the study by Giles and colleagues (2010) was the inclusion of patients 
residing in nursing homes, who were excluded from the other studies. 
Patient identification methods and capture rates 
The fracture liaison co-coordinator played a pivotal role in identifying eligible patients in all 
studies. This was performed in close collaboration with the staff of orthopaedic and 
emergency departments, including secretaries, nurses, allied health, and doctors. In the 
study by Giles and co-workers (2010), the successful utilization of an electronically derived 
patient list of relevant emergency department presentations, together with electronic 
prompts for referral on discharge letters, lead to the identification of all potentially eligible 
patients. Kuo and colleagues, recruited orthopaedic outpatients only. The other three 
studies recruited patients from varying combinations of orthopaedic ward, orthopaedic 
clinic, and the emergency department.  
The ‘capture rate’, refers to the proportion of eligible patients who underwent some form of 
intervention. Remarkably, Giles and co-workers (2010) reported 100% capture, because 
everyone with a minimal trauma fracture was identified and given some form of 
intervention, such as letter to the patient and PCP indicating the importance of osteoporosis 
assessment, which is a model C intervention (see below). In the same study, about 38% of 
patients underwent a ‘type A’ intervention by attending the osteoporosis clinic. Lih and 
colleagues (2011) reported a capture rate of 41%, while in the remaining two studies no 
information of capture rates was provided. Although not specifically addressed in the 
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studies, streamlining the process of referral to the FLS from the orthopaedic surgeon or 
primary care physician is paramount if a service is to improve capture and assessment rates. 
Interventions 
There are minor variations in the reporting of the intervention applied. In all studies, the 
FLS was an outpatient clinic run by a fracture liaison co-ordinator. The intervention 
included the following components: (i) Patient education, (ii) Assessment and investigation; 
and (iii) treatment initiation. Education components included aspects of nutrition and diet, 
exercise, risk factor reduction and falls prevention. A full risk factor assessment occurred in 
two of the four studies [Kuo et al, 2007; Lih et al, 2011]. Patients were assessed by bone 
mineral density and pathology testing in all studies, while routine thoraco-lumbar spine X-
rays were part of the evaluation in all but one study [Kuo et al., 2007]. Follow-up occurred 
annually in two studies [Vaile et al., 2007; Lih et al., 2011] but was not described in the 
remaining two reports. 
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Osteoporosis risk factor analysis was specifically described in two studies [Kuo et al., 2007; 
Lih et al., 2011]. For instance, Lih and co-workers reported 6.5% of patients had a prior non-
vertebral fracture, whilst Kuo and co-workers reported that half of patients had sustained 
prior fractures. Pathology testing for secondary causes of osteoporosis was reported in three 
studies [Kuo et al, 2007; Vaile et al., 2007; Lih et al, 2011]. Vaile and colleagues reported a 
positive coeliac screen in 0.2% of patients. Kuo and co-workers (2007) found new diagnoses 
of hyperthyroidism in 2.1% of patients, primary hyperparathyroidism in 1.4%, and 
hypovitaminosis D in 41% (i.e. 25-OH-vitamin D level < 50 nmol/L).  
b. BMD testing 
The rate of BMD testing in those attending the service ranged from 83% to 100%, although 
Giles and co-workers (2010) have not included this data in their report. The reported rates 
for BMD assessment contrast with a 10% uptake rate of BMD testing in an information-
based intervention (‘type D’) as per Kuo et al. 2007. 
c. Pharmacological treatment 
Lih and colleagues (2011) reported treatment rates of 79% in the intervention group 
compared to 31% in the control group. Vaile and colleagues (2007) revealed treatment rates 
were 51% in the intervention group compared to 11% in a historical control group. In this 
study, self-reported adherence at twelve months was 95%. In the study by Kuo and co-
workers (2007), 80% of patients were adherent to treatment at a mean follow-up of 10 
months with female gender and a diagnosis of osteoporosis being predictors of adherence.  
d. Re-fracture rates 
The only study describing re-fracture rates was by Lih and colleagues (2011). At four years 
of follow-up, a highly significant difference in re-fracture rates was reported: 4.1% in the 
group attending the fracture liaison service compared to 19.7% in the control group (Fig. 5). 
This difference corresponds to an 80% reduction in re-fracture rates in patients managed by 
a FLS.  
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e. Cost-effectiveness 
An informal evaluation of cost-effectiveness of a ‘type A’ intervention was described by 
Vaile et al. (2007), estimating that if one hip fracture is prevented, savings of AUD23,000 
could pay for the salary of a fracture liaison co-coordinator for six months, or for the 
osteoporosis evaluation of 54 patients with minimal trauma fractures.  
A formal and more comprehensive cost-effectiveness analysis of the Concord Hospital 
Fracture Liaison service by Cooper et al. (2011) revealed that the service was highly cost 
effective with a cost of around AUD 20,000 – 30,000 per QALY gained, depending on the 
model examined. As the Concord Hospital FLS is a typical ‘type A’ model, it can be safely 
assumed that most, if not all, comprehensive FLS are cost-effective interventions. 
f. Other outcome measures 
A further outcome measure reported Giles and colleagues (2010) was an improvement in 
referral of eligible patients by orthopaedic surgeons, physicians and general practitioners, to 
the osteoporosis clinic. Referral rates improved from 9% prior to the fracture liaison service, to 
34% after commencement of the fracture liaison service. Furthermore, the period of time from 
fracture occurrence to attendance at the osteoporosis clinic decreased from 68 days to 44 days.  
 
Fig. 5. Cumulative re-fracture incidence by groups (reproduced from Lih et al., 2011 with 
permission) 
5.1.2 ‘Type A’ fracture liaison services in the United States 
In the United States, orthopaedic surgeons have been the “champions” at the forefront of co-
ordinating osteoporosis care of patients after a minimal trauma fracture. In contrast to 
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Australia, some of the studies emanate from large, integrated health care networks, rather 
than individual hospitals. A good example is the Kaiser Permanente Group. This group is a 
health maintenance organization with 3.1 million members, spanning across eleven medical 
centres. The “Healthy Bones Program” consists of steps to identify patients at high risk of 
fractures, then assess and treat them for osteoporosis. The success of this program seems to 
be related to the utilization of a fully integrated electronic health record. The intervention 
consisted of a falls reduction program, assessment with DXA, evaluation for secondary 
causes, as well as a treatment plan. Monitoring occurred on a monthly basis, via reports for 
“care managers” (FLC) detailing those who needed treatment, and those who received 
treatment, thereby providing targets, and stimulating further improvements in care. 
Study types and patient characteristics 
Of the three studies from the United States, there was one ‘before and after’ analysis [Edwards 
et al., 2005], one prospective observational study [Dell et al., 2008], and one cross sectional 
study [Navarro et al., 2011]. All studies included males and females, with Edwards and co-
workers (2011) reporting that 75% of subjects were female. Racial background was reported by 
Navarro et al. (2005) with White subjects representing 64% of the sample. The numbers of 
subjects varied significantly in each study. Edwards and co-workers (2005) included 203 
subjects while in the remaining two studies from the Kaiser Permanente group, Navarro and 
co-workers included 13,412 subjects seen over a period of one year, and Dell and co-workers 
studied 620,000 subjects from 2002 to 2006. These large numbers were made possible by an 
electronically integrated health care system. In the latter two studies, inclusion criteria 
expanded beyond the patients with minimal trauma fractures to patients who had any risk 
factor for osteoporosis, including, for example, corticosteroid use or rheumatoid arthritis. All 
studies included patients with minimal trauma fractures at any site. 
Patient identification methods and capture rates 
All three studies utilized a fracture liaison co-coordinator. The Kaiser-Permanente model 
utilized health managers to identify care gaps through electronic lists, thereby identifying all 
patients in all settings (i.e. inpatients, outpatients, and emergency departments).  
Interventions 
All studies described a ‘type A’ FLS, which incorporated patient education, assessment and 
treatment initiation. All studies assessed and treated subjects on an outpatient basis.  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Information on the extent of patient assessment was generally limited, with only Edwards 
and colleagues (2005) reporting specific risk factor assessments. Specifically, 50% of patients 
had sustained prior fractures. Edwards and colleagues reported pathology testing for 
secondary causes of osteoporosis only in those with a BMD T-score less than -1.5 SD.  
b. BMD testing 
Navarro et al (2011) reported osteodensitometry testing and/or initiation of osteoporosis 
therapy in females of 92% as opposed to 75% in males, in a large cohort of 13,412 subjects. There 
was no disparity between racial groups. This is in contrast to the racial disparity in health care 
outcomes in the United States described by others [Wei et al. 2003, Epstein et al. 2010], 
indicating the significant societal benefits of an integrated electronic health care network. 
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The same group from Kaiser Permanente demonstrated that the implementation of their FLS 
resulted in an increase in bone mineral density testing from 21,557 tests in 2002 to 74,770 
tests in 2006 [Dell et al., 2008]. This represented a 600% increase in BMD testing for males, 
and a 220% increase for females. The rate of increase in men was greater than for women, 
possibly due to the very low rates of testing in men at baseline in 2002 (fig 6).  
c. Pharmacological treatment 
In the same study [Dell et al., 2008] the number of patients on treatment with specific anti-
osteoporosis medications increased from 33,208 in 2002 to 78,058 in 2006 (or from 24% to 
60% of at-risk subjects) as shown in Figure 7. Similar to the data on BMD testing, the rate of 
increase for men was greater than that for women.  
 
Fig. 6. Number of patients undergoing Dual X-ray Absorptiometry (DXA) for osteoporosis 
assessment [reproduced from Dell et al., 2008, with permission]. 
Edwards and co-workers (2005) reported improved treatment rates from 28% at baseline to 70% 
at six months post-discharge which then declined again to only 25% at twelve months post-
discharge. This precipitous decline in adherence at twelve months reflects the need for specific 
osteoporosis follow-up to reinforce the ongoing need for therapy.  
d. Refractures 
Dell at el (2008) described the effect of the Healthy Bones Program on hip fracture rates. 
While there was no concurrent control group, the authors elected to estimate expected rates 
of hip fracture based on historical data from 1997 – 1999, and then compared these historical 
data to the actual rate of hip fractures observed in patients cared for by the FLS. Overall, 
there was a 37.2% relative risk reduction in hip fractures, using data from 2006 (figure 8). 
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Fig. 7. Number of patients on specific anti-osteoporosis treatment [reproduced from Dell et 
al.,2008, with permission]. 
 
Fig. 8. Age stratified rate of hip fracture seen versus rate of hip fracture expected 
[reproduced from Dell et al., 2008, with permission]. 
e. Cost-effectiveness 
While there are no formal cost-effectiveness analyses for any of the US studies, one should 
remember that Kaiser Permanente is a closed health care network which pays for all 
expenses but also benefits from all savings. The fact that a private provider such as Kaiser 
Permanente has fully integrated a ‘type A’ FLS into their health care program strongly 
suggests that the model is not only cost-effective but actually cost-saving.  
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5.1.3 ‘Type A’ fracture liaison services in Canada 
Study types and patient characteristics 
Three ‘Type A’ FLS have been described in a series of five publications – three randomized 
controlled trials (RCT) from the same FLS [Majumdar et al., 2007 & Morrish et al., 2009; 
Majumdar et al., 2011], and one cross-sectional study [Bogoch et al., 2006]. The first two 
randomized controlled trials compared three different FLS models: firstly a ‘type A’ versus 
‘type D’ model of care [Majumdar et al., 2007] and secondly a ‘type A’ versus ‘type B’ model 
of care [Morrish et al., 2009] in patients with hip fractures. The third RCT by the same group 
involved patients with wrist fractures, comparing a ‘type A’ with ‘type C’ intervention 
[Majumdar et al, 2011]. The three services included both males and females, with the 
proportion of females varying from 65% to 77%. Patient numbers varied significantly in that 
the randomized controlled trials [Majumdar et al., 2007 & Morrish et al., 2009] had 110 
patients in each arm, whilst the trial by Majumdar et al. (2011) had a total of 46 patients. The 
cross-sectional study evaluated 430 patients. The target population in the RCT’s were 50 
years of age and over. Between 82% and 95% of patients were white Caucasian. Bogoch and 
co-workers (2006) included female patients older than 40 years, and male patients over 50 
years of age, with a minimal trauma fracture to the hip, wrist, humerus or vertebra.  
Patient identification methods and capture rates 
All three services utilized a Fracture Liaison Co-coordinator to identify eligible inpatients 
and outpatients. Bogoch et al. (2006) also engaged the orthopaedic staff in the identification 
process. There was no indication as to the completeness of identification of eligible patients.  
Intervention methods 
In all three studies, the FLC coordinated the identification, assessment (clinical risk factors, 
osteodensitometry, pathology) and treatment of patients with a fragility fracture. In the 
studies by Majumdar and Morrish it was specified that a letter was sent to the primary care 
physician once treatment was initiated.  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Osteoporosis risk factors were evaluated in all studies. A past history of minimal trauma 
fractures was documented in 37% (Majumdar et al 2007 & Morrish) and 26% (Bogoch). 
Majumdar and colleagues (2011) was the only trial which stated pathology testing for 
secondary causes of osteoporosis were performed, although the proportion of positive 
results was not reported. 
b. BMD testing and treatment rates 
In the study by Majumdar et al. (2007), 80% of patients in the intervention group underwent 
BMD testing at six months post-fracture, compared to only 29% in the control group. About 
51% of patients in the intervention group were commenced on bisphosphonates at six 
months, compared to 22% in the control group. A further result reported was “Appropriate 
Care”, which was defined as the proportion of patients commenced on bisphoshponates 
when the BMD T-score was < -1.5 SD. Appropriate care was achieved in 67% of patients in 
the intervention group, versus 26% in the control group. The underlying cause of the low 
rate of appropriate care was not reported. 
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As an extension of the above trial, patients assigned to the control group (‘standard care’) 
were allocated to a new intervention after six months. This new intervention consisted of a 
BMD scan organised by the FLC (‘Type B’ intervention) with results being sent to the 
primary care physician [Morrish et al. 2009]. As a result, the rates of BMD testing, treatment 
with a bisphosphonate, and “appropriate care” improved compared to usual care (‘Type D 
intervention’), but not to the extent of case management (‘Type A’ intervention) (fig. 9).  
 
Fig. 9. Comparison of case manager, facilitated BMD testing, and usual care in patients with 
a hip fracture [reproduced from Morrish et al., with permission]. 
A further study by Majumdar et al. (2011) which included patients with wrist fractures only, 
revealed a BMD testing rate of 81% (‘type A’) versus 52% (‘Type C’). The rate of 
bisphosphonate treatment was better with intensive intervention, at 43% (‘type A’) versus 
12% (‘type C’).  
In the study by Bogoch et al (2006), the proportion of all patients who were previously 
diagnosed and treated for osteoporosis was 34%, which is higher than expected from the 
published literature. This study also reported a rate of “appropriate attention” for 
osteoporosis of 96%, which encompassed referral, diagnosis or treatment of osteoporosis. 
This unique outcome measure is a good example of the heterogeneity of outcome reporting 
in various studies, making direct comparison between studies problematic. Reiterating the 
gender disparity, women (39%) were more likely than men (15%), to have had diagnosis and 
treatment for osteoporosis prior to their fracture.  
c. Re-fractures 
Morrish et al. (2009) reported 10 new fractures after a limited follow-up of twelve months. 
While the authors state that there was no difference in re-fracture rates between groups, 
they did not specify how many fractures occurred in each arm of the study. Thus, it is likely 
that the study was underpowered to allow any conclusions on reductions in fracture risk.  
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d. Cost-effectiveness 
Sander and colleagues (2008) performed a cost-effectiveness analysis of the ‘type A’ model 
of care described by Bogoch et al. (2006). The FLS was predicted to reduce the annual hip 
fracture rate from 34 with usual care, to 31, resulting in a cost saving of C$ 49,950. This cost-
saving held true assuming at least 350 patients were seen by the FLS over a year. The two 
limitations of this analysis was firstly, the lack of a control group, resulting in the need to 
make assumptions in the usual care group based on historical data. Secondly, the cost-
saving may not be translated to smaller institutions which have a lower volume of patients 
seen in the FLS. There was no formal cost-effectiveness evaluation for the RCT by Majumdar 
et al. (2007) and Morrish et al. (2009), although it was reported that the ‘type A’ model of 
care evaluation cost $56 versus $24 for a ‘type B’ model of care.  
5.1.4 ‘Type A’ fracture liaison services in Europe 
Study types and patient characteristics 
Two cross-sectional studies have described the implementation of a ‘Type A’ fracture 
liaison service, one from the United Kingdom [Clunie et al., 2008] and one from France 
[Boudou et al., 2011]. Clunie and co-workers recruited 2491 male or female patients older 
than 50 years with a minimal trauma fracture at any site. More than 50% of patients had a 
hip or wrist fracture. The study by Boudou et al. (2011), evaluated 155 female patients 
over 50 years of age with wrist, humerus or femur fractures. Racial background was not 
reported in either study.  
Patient identification methods and capture rates 
In the study by Clunie et al, (2008), patients were identified in either outpatient or inpatient 
settings by a FLC. It is unclear as to the proportion of potentially eligible patients who were 
identified. The study from France also employed a FLC, who utilized an electronic medical 
record system to identify patients. More that 90% of patients were identified, with only 20% 
of patients captured for evaluation by the FLS. 
Intervention methods 
In both studies, patients underwent a complete risk factor assessment, including 
pathology tests for secondary causes of osteoporosis as well as BMD testing. According to 
Clunie et al (2008), patients were referred to the Bone clinic when appropriate. Patients 
more than 75 years of age were assessed for falls risk and referred to the primary care 
physician. The schema for this service is shown in Figure 10, as another example of a 
‘Type A’ intervention.  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Patients in both studies underwent risk factor assessment and investigations for secondary 
causes of osteoporosis. Notably, Clunie et al. (2008) quoted their previous publication 
relating to the same service, whereby 6% of patients routinely screened for secondary causes 
of osteoporosis regardless of osteodensitometry results, had a new diagnosis such as 
hyperthyroidism or primary hyperparathyroidism [Clunie et al., 2005].  
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b. BMD testing 
Clunie and colleagues (2008) reported a high rate (91.2%) of osteodensitometry in those 50-
69 years of age, whereas the rate of osteodensitometry was not reported by Boudou and co-
workers (2011). 
 
Fig. 10. Structure of ‘Type A’ fracture liaison service [reproduced from Clunie et al. 2008, 
with permission]. 
c. Pharmacological treatment 
In the trial by Boudou et al. (2011), approximately 90% of patients initiated treatment 
prescribed by the FLS, and 80% of these remained on treatment at one year follow-up. After 
a further follow-up of 27.4 +/- 11.7 months, 68% of patients were persistent with treatment. 
This trial represents one of the very few studies that report adherence data within the 
setting of a FLS. Reasons for discontinuation of therapy were adverse events, lack of 
primary care physician encouragement, and polypharmacy. Clunie and colleagues (2008) 
did not report treatment rates. 
d. Re-fractures 
After a mean follow-up period of 27.4 +/-11.7 months, 11.4% had sustained a further fracture 
[Boudou et al. 2011]. The rate of further fractures was not described by Clunie et al. (2008). 
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e. Cost-effectiveness 
Nil data. 
5.2 Appendix B 
5.2.1 ‘Type B’ fracture liaison services in Europe 
5.2.1.1 United Kingdom 
In the United Kingdom, there has been a concerted, collective effort towards re-fracture 
prevention by attempting to establish fracture liaison services in all hospitals based on the 
Glasgow FLS model [Mitchell 2011]. The strong advocacy towards re-fracture prevention has 
been supported and catalysed by patient and professional organisations (e.g. the UK National 
Osteoporosis Society), the government (through integration into a policy framework and 
providing financial incentives to health providers who adhere to the guidelines), and 
pharmaceutical companies (through provision of funding). The publication of the second 
edition of the ‘Blue Book’ in 2007 provided comprehensive guidelines to promote high quality 
care of minimal trauma fracture patients in the UK. Specifically, the ‘Blue Book’ provides 
guidelines and standards of care for the peri-operative management of patients with a minimal 
trauma fracture (particularly hip fractures), as well as guidelines on secondary fracture 
prevention through fracture liaison services. The third major component of the ‘Blue Book’ 
details the importance of contributing to and utilising the National Hip Fracture Database 
(NHFD) allowing the benchmarking of hip fracture care across the UK, thereby catalysing 
improvements in clinical care. Critical to the implementation of these guidelines was the multi-
disciplinary authorship and the strong endorsement it received from most relevant professional 
organisations. As a testimony to the success of the program, all 200 hospitals in England, Wales 
and Northern Ireland have subscribed to the database. In addition, the most recent report from 
the NHFD in 2010 describes 75% of 36,000 hip fracture patients receiving assessment or 
treatment for osteoporosis prior to being discharged from hospital. 
Study types and patient characteristics 
There are four publications describing FLS in the UK, originating from two services. The 
first two were cross-sectional studies describing the Glasgow FLS, which is the model upon 
which most FLS in the UK are built [McClellan et al., 2003, 2011]. A case control study of the 
same service evaluated characteristics of those with re-fractures [Langridge et al., 2007]. The 
second service based in Royal Manchester Infirmary was described in a ‘before and after’ 
analysis [Charalambous et al., 2002]. The Glasgow FLS included 4,671 patients, older than 50 
years, who sustained a minimal trauma fracture over an 18 month period. Both male and 
female patients were included. Approximately 30% of patients sustained wrist fractures, 
and about 23% had sustained hip fractures. Exclusion criteria included patients with skull or 
facial fractures, patients with dementia, or those unable to tolerate oral bisphosphonate 
therapy. The study by Charalambous was limited to only female patients with a minimal 
trauma fracture to the wrist and hip. The number of patients was also smaller, with 100 pre-
intervention and 66 in the intervention phase.  
Patient identification methods and capture rates 
The Glasgow service utilized a fracture liaison co-coordinator to capture patients from 
orthopaedic wards, orthopaedic outpatient clinics, as well as the emergency department. 
www.intechopen.com
 Primary Care at a Glance – Hot Topics and New Insights 
 
308 
The co-coordinator visited wards regularly, with patient lists maintained by close contact 
with orthodpaedic staff, and utilizing the hospital information technology systems. Thus, 
almost 100% of patients were identified; although only 78% attended the service (22% had 
declined the intervention). Charalambous and colleagues (2002) identified orthopaedic 
inpatients and outpatients, using a monthly list of patients with new fractures. Instead of a 
co-coordinator, a protocol was instituted to refer patients for osteoporosis evaluation or 
direct referral for BMD. No comment was made regarding the proportion of potentially 
eligible patients identified.  
Intervention methods 
The Glasgow service provided patient education, together with outpatient assessment, followed 
by treatment recommendations to the PCP. On the other hand, Charalambous and colleagues 
did initiate inpatient assessment of those with hip fractures (older than 60 years), with direct 
referral for BMD, followed by recommendations for further assessment and treatment.  
Outcomes 
a. Risk factor analysis and pathology screening for secondary causes 
Risk factor assessment was performed in both studies while pathology screening for 
secondary causes of bone loss was described only in the Glasgow service. The results of 
pathology screening was not reported. 
b. BMD testing and treatment 
The first set of outcome data for the Glasgow service revealed that 44% of patients 
underwent BMD testing, compared to 10% in historical controls, and 29% of patients were 
recommended pharmacotherapy [McLellan et al. 2003]. The most recent outcome data from 
the Glasgow FLS evaluated the rate of patient capture, assessment, treatment, and cost-
effectiveness over 8 years of service provision [McLellan et al. 2011]. A total of 11,096 
patients were identified, of whom 8,875 (80%) were assessed. The number of patients who 
underwent BMD scans was 5,405 (49%). Oral bisphosphonate treatment was recommended 
in 54%, whilst 1,273 (11%) were on treatment previously. As a testimony to the effectiveness 
of a close liaison between the FLS and the PCP, the study found that 96% of patients had the 
recommended treatment initiated in primary care. Treatment persistence was reported as 
86% at 12 months.  
At Manchester Royal Infirmary the implementation of a protocol was shown to be effective 
in improving “appropriate osteoporosis management” in female patients [Charalambous et 
al. 2002]. In this study, “appropriate management” simply entailed initiating a referral to a 
doctor for evaluation of osteoporosis, or initiation of calcium and vitamin D as per protocol.1  
Pre-intervention, 22% (11/50) of in-patients with hip fractures and 0% of patients with distal 
radial fractures received “appropriate management”. Post-intervention, the corresponding 
numbers were 76% and 81%, respectively.  
                                                 
1 This highlights the differences in the definition of ‘appropriate care’, which appears to be a term of 
considerable heterogeneity. Thus, a number of studies define ‘appropriate care’ as a clinical assessment 
with or without a BMD scan, with or without initiation of treatment. Other definitions refer to receiving 
osteoporosis treatment in keeping with the local guidelines, based on T-scores. 
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c. Re-fractures 
The South Glasgow service published data from January 2001 to August 2004 with up to 3.5 
years follow-up of patients older than 65 years [Langridge et al. 2007]. Of the 2,489 patients 
seen by the service, 129 had re-fractured (5.2%). About 37% of these patients were taking 
calcium, vitamin D and a bisphosphonate. Unfortunately there was no control group to 
which these results could have been compared. On the other hand, McLellan et al. (2011) 
reported a 12% rate of re-fracture over 4 years for the West Glasgow service. 
d. Cost-effectiveness 
The cost-effectiveness analysis of the Glasgow service was based upon an 8% re-fracture rate 
at 4 years, although the actual re-fracture rate was reported to be 12% [McLellan et al., 2011]. 
The cost per Quality Adjusted Life Year (QALY) gained was 5,740 pounds. According to the 
least favourable efficacy data, fifteen fractures are avoided, at the expense of 84,076 pounds 
per 1000 patients. According to the most favourable efficacy data, thirty six fractures are 
avoided and 199,132 pounds saved per 1000 patients. Using a hypothetical cohort of 1000 
patients, it was estimated there would be 18 fewer fractures with the fracture liaison service. 
These results illustrate the effectiveness of a ‘type B’ intervention in the UK setting.  
5.2.1.2 ‘Type B’ fracture liaison services outside the UK 
Study types and patient characteristics 
There are three cross-sectional studies describing ‘type B’ models of care in Switzerland 
[Chevalley et al., 2002], Sweden [Astrand et al., 2006], and the Netherlands [Huntjens et al., 
2010]. The study from the Netherlands compared five large FLS within the same health care 
system. All of these European FLS enrolled both male and female patients 50 years of age or 
older, who presented with a minimal trauma fractures at any site. The proportion of female 
patients seen in each service ranged from 70% to 88%, with a mean of 78%. The proportion 
of patients who sustained wrist fractures varied from 3.6% to 58%, with a mean of 27%. The 
proportion of patients who sustained hip fractures varied from 1.0% to 45%, with a mean of 
13%. The number of patients in each study varied from 238 to 2224. The follow-up period 
ranged from 12 months to 58 months, with a mean of 43 months. The number of patients 
seen per centre per month varied from 11 to 47, with a mean of 25. In all studies, dementia 
and pathological fractures were excluded. In the Swedish study, patients who were out of 
area and non-English speaking were excluded.  
Patient identification methods and capture rates 
All seven fracture liaison services (apart from Chevalley and colleagues) utilized a co-
coordinator to identify patients from the wards, orthopaedic outpatients, the emergency 
department or radiology. Two sites from the Netherlands utilized radiology reports alone to 
identify eligible patients. Three services (two from Netherlands and the Swedish study) 
incorporated electronic medical record and the co-coordinator to identify patients. The 
proportion of eligible patients identified, who attended the service was not described.  
Intervention methods 
In all studies patients underwent osteoporosis assessment and treatment recommendations as 
outpatients, with components as would be expected from the ‘type B’ intervention. The details 
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of intervention methods are not described by Huntjens et al. (2010), although Chevalley and 
colleagues (2002) described a multidisciplinary educational intervention. The extent to which 
the services educated patients is unclear in the studies from the Netherlands.  
Outcomes 
a. Risk factor analysis and pathology screening for secondary causes 
The assessment of risk factors was described in all seven studies. Six of the seven services 
reported pathology screening for secondary of osteoporosis (apart from Astrand and co-
workers); however the threshold varied between fracture liaison services. For instance, in 
the Netherlands, two FLS reported performing screening tests for secondary causes of 
osteoporosis in patients younger than 70 years, with a T-score equal to or less than -3.0 SD, 
whilst another would do so in any patients with a BMD T-score less than -2.0 SD. A fourth 
FLS in the Netherlands, investigated only men for secondary causes of osteoporosis.  
b. BMD testing 
All fracture liaison services performed bone mineral density testing. However, only 
Chevalley et al. and Astrand et al. reported the actual proportion of patients undergoing 
BMD testing (63% and 93% respectively).  
c. Pharmacological treatment 
Treatment outcomes were only reported by Chevalley and colleagues - about 33% of 
patients were recommended anti-osteoporosis medication, of which 66% were initiated on 
therapy. Adherence declined to 67%, at six months follow-up.  
d. Re-fractures 
Nil data 
e. Cost-effectiveness 
Nil data 
5.2.2 ‘Type B’ fracture liaison services in the United States 
Study types and patient characteristics 
In the two ‘before and after’ studies from the United States, the study by Johnson et al. 
(2005) focused on male patients (96% of the study population), while the second report 
included mainly female patients [Cuddihy et al., 2004]. The study by Johnson et al. analysed 
outcomes in 126 pre-intervention and 136 post-intervention subjects (mean age: 60 years; 
64% white Caucasian). Of note, this study looked at all fracture types, including high 
trauma fractures. As a result, only 32% of fractures were due to ‘minimal trauma’. Cuddihy 
et al. recruited 96 subjects aged 44yrs or older with a minimal trauma fracture to the wrist 
(mean age: 68 years).  
Patient identification methods and capture rates 
Both services utilized fracture liaison co-coordinators, who accessed an electronic database 
to identify patients, from either orthopaedic clinics or wards. Cuddihy et al. reported 100% 
identification of potentially eligible patients, made possible by the electronic database. 
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About 61% of those identified attended the fracture liaison service. Johnson and colleagues 
did not report the rate of identification of potentially eligible patients. 
Intervention methods 
As is standard in a ‘type B’ model of care, patients in both groups were assessed for 
osteoporosis by performing a BMD scan, followed by a referral to the primary care 
physician with treatment recommendations.  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Evaluation of risk factors for osteoporosis was specifically reported by Cuddihy et al. (2004), 
with 37% (19/51) of women and 50% (4/8) for men sustaining prior fractures. Johnson et al. 
(2005) reported evaluation of osteoporosis risk factors in only the intervention group who 
underwent BMD testing. Cuddihy et al. (2004) did not detect any secondary causes for 
osteoporosis after assessing 32 out of 59 patients, whilst Johnson et al (2005) did not report 
screening for secondary causes.  
b. BMD testing 
Osteoporosis assessment increased from 16% at baseline, to 45% at six months, although 
males had a lower rate of BMD testing compared to females [Cuddihy et al. 2004]. In the 
study by Johnson et al., the rate of BMD testing changed from 13% (16/126) in the pre-
intervention group to 63% (85/136) in the intervention group.  
c. Pharmacological treatment 
Adherence to osteoporosis specific treatment increased from 9% to 36% at six months 
[Cuddihy et al., 2004]. In the study by Johnson et al., the proportion of patients 
recommended specific osteoporosis medications increased from 7% to 19%, which is a 
surprisingly low number, although the majority of patients had traumatic fractures. At six 
months following the intervention, only 6% of patients in the pre-intervention group were 
receiving specific osteoporosis treatment, compared to 13% for the intervention group.  
5.2.3 'Type B’ fracture liaison services in New Zealand 
Study types and patient characteristics 
A single ‘before and after’ study from New Zealand reported on 329 subjects in a pre-
intervention group, and 193 subjects in the intervention group, of whom 78% were women. 
About 69% of patients had sustained a hip fracture [Sidwell et al. 2004]. 
Patient identification methods and capture rates 
Patient identification did not require a fracture liaison nurse, because an inpatient protocol 
was implemented in an ortho-geriatrics ward. Therefore, existing staff were educated to 
implement the protocol. It is unclear if all potentially eligible patients were captured. 
Intervention methods 
Staff identified patients with a minimal trauma fracture, assessed them with BMD scan and 
pathology tests, and sent a report to the primary care physician with treatment 
recommendations. 
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Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
The evaluation of risk factors for osteoporoisis was not reported, although pathology testing 
for secondary causes of osteoporosis was performed in 63% of patients. 
b. BMD testing 
BMD testing increased from 11% (pre-intervention group) to 78% in the intervention group. 
c. Pharmacological treatment 
At nine months post-fracture, those on calcium or vitamin D increased from 13% to 52%. 
Bisphosphonates or HRT prescription increased from 10% to 31%. 
d. Re-fractures 
Nil data. 
e. Cost-effectiveness 
Nil data. 
5.3 Appendix C 
5.3.1 ‘Type C’ fracture liaison services in the United States 
Study types and patient characteristics 
We identified six reports describing a ‘type C’ intervention in the United States. Three 
were randomised controlled trials (RCT’s) [Gardner et al., 2005; Feldstein et al., 2006 & 
Solomon et al., 2007], one was a cross-sectional design [Skedros et al., 2004], and two were 
‘before and after’ studies, described in the same article [Harrington et al., 2005]. One 
study included only female patients [Harrington et al., 2005], whilst the other five studies 
included both male and female patients. The proportion of females reported in two 
studies was 78% and 86% [Skedros et al., 2004; Gardner et al., 2005]. Two studies included 
only patients with hip fractures [Gardner et al., 2005; Harrington et al., 2005], whilst the 
other studies included patients with minimal trauma fractures at any site. The total 
number of patients in each study varied from 69 to 1973, with the median number of 
participants in each study being 283. Most studies recruited patients greater than 50 years 
of age. Three studies specified exclusion criteria, such as dementia, nursing home 
residence and previous osteoporosis investigation or treatment [Skedros et al., 2004; 
Gardner et al., 2005; Feldstein et al., 2006].  
Patient identification methods and capture rates 
A fracture liaison co-coordinator was critical to the implementation of each service, apart 
from one [Skedros et al, 2004], in which orthopaedic surgeons were asked to educate and 
recommend further assessment for osteoporosis. In three studies electronic medical records 
were employed to help with identification of patients [Harrington et al., 2005; Feldstein et 
al., 2006; Solomon et al., 2007]. The settings in which the intervention took place varied from 
exclusively outpatient or inpatient, to mixed settings.  
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Intervention methods 
The methods of intervention did not differ significantly between four of the six studies. 
Uniquely, one RCT compared three groups, using varying degrees of educational 
interventions [Feldstein et al. 2006]. This study was a well-powered, randomised controlled 
trial of female patients only. The three groups were ‘usual care’ (n=101), electronic reminder 
to PCP (n=101), and electronic reminder to PCP with educational letter mailed to the patient 
(n=109). Thus, there was an effective comparison between different ’type C’ intervention 
and no intervention at all. Another randomised controlled study used an educational 
intervention consisting of a one-on-one interview with a PCP by a pharmacist, together with 
a letter and automated phone call to patients regarding the assessment of their bone health 
[Solomon et al., 2007]. 
Outcomes 
a. Risk factor analysis and Blood tests for secondary causes 
Evaluation of risk factors was reported in only one trial [Harrington et al., 2005]. As 
expected from an educational intervention, pathology testing was not performed, and a 
clinical risk factor assessment was not a part of this model.  
b. BMD testing and Pharmacological treatment 
Five studies reported on the outcome of BMD testing and/or treatment with specific anti-
osteoporosis therapies with follow-up periods varying from six months (3 studies) to 18 
months. The intervention effect ranged from 14% to 46%, with the control or baseline results 
ranging from 5% to 19%. The average improvement compared to baseline was 23% across all 
studies. Of interest, the study by Solomon et al. (2007) failed to detect a clinically significant 
improvement in BMD testing or treatment (14% in intervention group vs. 10% in control 
group). This is in stark contrast in to all other studies with similar interventions.  
Feldstein and co-workers (2006) reported improved BMD testing rates at six months in the 
intervention group (20%), compared to 5% in the control group. Treatment rates were 20% 
and 30% in studies by Feldstein and Skedros respectively. 
c. Re-fractures 
Solomon et al. reported no difference in re-fracture rates at 10 months follow-up, but the 
study was not powered for this outcome. No other studies reported on re-fractures. 
d. Cost-effectiveness 
Nil data. 
5.3.2 ‘Type C’ fracture liaison services in Canada  
Study types and patient characteristics 
We identified five reports on ‘Type C’ models of care from Canada. The study types include 
one randomized controlled trial [Majumdar et al., 2008], two prospective controlled trials 
[Ashe et al., 2004; Majumdar et al., 2004], one ‘before and after’ analysis [Hawker et al., 
2003], and one cluster randomized trial [Cranney et al., 2008]. All studies included both 
male and female patients, with the proportion of females ranging between 74%-78%. Racial 
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background was described as mostly White in one study [Hawker et al., 2003], and 79% 
White in the study by Majumdar and co-workers (2004). The numbers of patients in each 
study varied from 51 to 278, with the mean number of participants per study of 195. Most 
studies recruited patients above 49 years of age, with a mean age of 67 years. All of the trials 
apart from one [Hawker et al., 2003] included patients with minimal trauma fractures to the 
wrist only, although one study included moderate trauma wrist fractures as well [Ashe et 
al., 2004].  
Patient identification methods and capture rates 
Three studies utilized fracture liaison co-coordinators [Ashe et al., 2004; Majumdar et al., 
2004, Majumdar et al., 2008], whilst one study utilized existing staff [Cranney et al., 2008], 
and another enlisted the help of the orthopaedic surgeons to identify eligible patients 
[Hawker et al., 2003]. Patients were identified in the emergency department and orthopaedic 
clinics.  
Intervention methods 
Intervention methods for ‘type C’ services have been described in section 2.5 and all of the 
Canadian services adhered to this model, with little to no variation between studies. 
Outcomes 
a. Risk factor analysis 
Analysis of osteoporosis risk factors was reported in two studies [Hawker et al., 2003; 
Majumdar et al., 2008]. Hawker and co-workers reported the rate of prevalent fractures 
amongst subjects of 20%, whilst Majumdar and co-workers reported a rate of 48%.  
b. BMD testing 
The rate of BMD testing and/or treatment was reported by Majumdar et al., 2004 & 2008. In 
the 2004 study, at six months, the intervention group did better than the control group (71% 
versus 21%). In the 2008 study, 38% of the intervention group versus 11% of the control 
group underwent BMD testing and / or treatment. The average improvement in the 
outcome was 38.5%.  
The rate of BMD testing was reported in all studies, at three to six months follow-up. The 
rate of BMD testing in the intervention group ranged from 43% to 92%, and in the control 
group ranged from 18%-28%. The average improvement in BMD testing was 40%.  
c. Pharmacological treatment 
Three studies reported the rates of anti-osteoporosis treatment after three to six months 
follow-up [Hawker et al., 2003; Majumdar et al., 2004 and 2008]. The rate of treatment in the 
intervention groups ranged from 11% to 40%, compared to 7%-10% in the control groups. 
The average improvement in treatment rates was 15%. The significant variability in results 
between studies may be due to factors which are difficult to report such as the details of the 
explanation of osteoporosis, and rapport between co-coordinator and patients.  
d. Re-fractures 
Nil data. 
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e. Cost-effectiveness 
Nil data.  
5.3.3 ‘Type C’ fracture liaison services in Australia 
Study types and patient characteristics 
Inderjeeth and colleagues (2010) from Perth, Western Australia, published a ‘before and 
after’ study, using a historical control group. There were 200 patients in the pre-intervention 
group and 194 in the intervention group. The educational intervention targeted patients 
discharged directly from the emergency department, older than 65 years with a minimal 
trauma fracture at any site. 
Patient identification methods and capture rates 
Patient identification occurred by utilizing existing hospital staff (e.g. emergency 
department clinicians), and primary care physicians were made aware of the need for 
osteoporosis assessment in these patients. Approximately 34% of eligible patients 
underwent the intervention.  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Nil data 
b. BMD testing 
At 12 months follow-up, the rate of BMD testing was 45% in the intervention group vs. 3% 
in the pre-intervention group.  
c. Pharmacological treatment 
Calcium and vitamin D supplementation increased from 12% to 37%. Initiation of 
osteoporosis specific treatment increased from 6% to 30%. 
d. Re-fractures 
Nil data. 
e. Cost-effectiveness 
Nil data. 
f. Other outcome measures: 
Referral to the bone clinic increased from 4% pre-intervention to 26% with the intervention. 
5.4 Appendix D 
5.4.1 Description of ‘Type D’ model of care fracture liaison Services 
Study types and patient characteristics 
We have identified three publications describing ‘type D’ interventions, two from Australia 
[Bliuc et al., 2006; Diamond and Lindenberg et al., 2002] and one from Canada [Bessette et 
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al., 2011]. Two were randomized controlled trials [Bliuc et al. and Bessette et al.] while the 
third was a cross-sectional analysis [Diamond and Lindenberg, 2002]. In the two Australian 
studies, 65% of patients were females with an average of 160 subjects in each study. On the 
other hand, the Canadian study recruited 1314 patients who were all female. Bliuc and 
colleagues recruited patients over 20 years of age, with one–third sustaining a moderate 
trauma fracture. Diamond and Lindenberg included patients 45 years or older with minimal 
trauma fractures. Bessette and co-workers included patients above 49 years of age who 
sustained a ‘minimal trauma’ fracture at any site. As an indicator of heterogeneity between 
studies even of the same ‘type’, ‘minimal trauma’ was defined as a fall from a height of one 
metre or less by Bessette and colleagues. This contrasts with most other studies, define 
‘minimal trauma’ as a fall from standing height or less. 
Patient identification methods and capture rates 
Diamond and Lindenberg identified patients from a private radiology practice, who had 
sustained a minimal trauma fracture. No co-ordinator was required for this study. About 
64% of eligible patients were contacted. On the other hand, Bliuc and colleagues identified 
patients from the orthopaedic clinic via a fracture liaison co-ordinator. About 46% of eligible 
patients received the intervention. Bessette and colleagues identified patients from hospital 
orthopaedic clinics, as well as from the Quebec Ministry of Health database. 
Intervention methods 
In the study by Diamond and Lindenberg, patients were asked to fill out a survey about 
osteoporosis, encouraging them to have their bone health assessed. Bliuc and colleagues 
randomised patients to receiving either a letter educating patients about osteoporosis risk 
factors, or a similar letter together with an offer for a free BMD scan. Bessette and colleagues 
divided their cohort into three groups: i) control group ii) letter to patient group iii) letter to 
patient together with 15min video. 
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Bliuc and colleagues as well as Bessette and co-workers, reported osteoporosis risk factors 
extensively in both groups, with well matched baseline characteristics. About 46% (Bliuc et 
al.) and 24% (Bessette et al.) of patients had a prior fracture. There was no information on 
risk factors by Diamond and Lindenberg, and neither study reported on testing for 
secondary causes of osteoporosis. . 
b. BMD testing 
In the study by Bliuc and colleagues, at six-months follow-up, the rate of BMD testing was 
38% in those offered the BMD scan compared to 7% in patients who received a letter only. 
Female sex was a predictor for having a BMD performed. Diamond and Lindenberg 
reported a rate of BMD testing of 51% at twelve months. Bessette and co-workers revealed a 
very small effect of the intervention, with only 15% undergoing BMD testing compared to 
12% in the control group. 
c. Pharmacological treatment 
Diamond and Lindenberg reported that 29% of patients were commenced on specific anti-
osteoporosis treatment following the intervention, none of whom were men. This indicates 
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the significant gender disparity often evident in osteoporosis management. Bliuc and 
colleagues reported treatment rates of 6% (free BMD scan group) and 5% (letter only group), 
at six months, reflecting the limited effectiveness of a ‘type D’ intervention. Bessette and 
colleagues reported a treatment rate of 11% (intervention) versus 8% without the 
intervention, which is not a clinically significant difference. 
d. Re-fractures 
Nil data 
e. Cost-effectiveness 
Nil data 
5.5 Appendix E 
5.5.1 Description of ‘Type E’ model of care fracture liaison services 
Study types and patient characteristics 
We have identified six studies describing ‘type E’ interventions in the United States [n=3 - 
Kamel et al., 2000; Jachna et al., 2003; Streeten et al., 2006], Australia [n=2 – Jones et al., 2005; 
Chong et al., 2008] and the United Kingdom [n=1 – Wallace et al., 2011]. There were five 
cross-sectional studies and one ‘before and after’ analysis [Jones et al., 2005]. In the majority 
of cases patients included were inpatients who had minimal trauma fractures to the hip, 
with females representing approximately 67% of the subjects. The number of patients in 
each study varied from 82 to 834, with a median number of patients of 170. At 80 years, the 
mean age of subjects was significantly greater than in the other intervention models.  
Patient identification methods and capture rates 
Only one of the studies utilized a fracture liaison co-coordinator [Wallace et al., 2011], whilst 
two studies had an inpatient protocol for existing staff to use [Jones et al, 2005; Streeten et 
al., 2006]. One study asked the orthopaedic team to identify eligible patients [Chong et al., 
2008].  
Intervention methods 
Intervention methods varied from an inpatient fracture protocol, to the involvement of an 
ortho geriatrics team. In one study, the protocol was introduced to all rotating interns, 
providing guidelines for commencement of anti-resorptive therapy and ortho geriatric 
consultation [Jones et al., 2005].  
Outcomes 
a. Risk factor analysis and pathology testing for secondary causes 
Two studies reported risk factor analysis [Streeten et al., 2006; Wallace et al., 2011] as well as 
pathology testing as part of the intervention [Streeten et al., 2006; Jones et al., 2005]. 
Reflecting an older and sicker cohort than in the other intervention types, Jones and 
colleagues found that 77% of patients had hypovitaminosis D (i.e., 25-OH-vitamin D level 
below 50 nmol/L) and 34% of patients had secondary causes for osteoporosis identified.  
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b. BMD testing 
Implementation of a strategy using an inpatient protocol appeared to be more effective in 
initiating BMD testing compared to a general medical consultation. Such protocols resulted 
in BMD testing rates of 66% versus 3% in the absence of a protocol [Streeten et al., 2006]. 
c. Pharmacological treatment according to intervention type 
The rate of inpatient bisphosphonate prescription increased from 5% pre-intervention to 
24% with and after the intervention (inpatient protocol) [Jones et al., 2005]. Wallace and 
colleagues (2011), showed improved treatment rates of 90.5% for hip fracture patients in a 
hospital with an ortho-geriatric service as well as a FLS, compared to 60.5% in a hospital 
with an ortho-geriatrics service only.  
Inpatient physician consultation for patients admitted with a minimal trauma fracture to the 
hip is ineffective in improving osteoporosis care. That is, at discharge only 7% of patients 
were on bisphosphonates in one study [Jachna et al. 2003], and 5% in another study [Kamel 
et al. 2000]. It is important to note that these were retrospective chart reviews, and that the 
consulting physicians were not asked to specifically manage the patients’ bone health. 
Specific inpatient Endocrinology consultation for osteoporosis has been shown to be partly 
effective [Streeten et al, 2006] when compared to no consultation, in a study with 84 subjects. 
The intervention improved calcium and vitamin D commencement (75% vs 3%), and 
Bisphosphonate commencement (68% vs. 0%). Of those followed-up, 79% vs. 17% were 
taking calcium or vitamin D, and 65% vs. 0% taking a bisphosphonate (of those contacted). 
However, the mean follow-up was much longer for the non-intervention group (39 months) 
compared to the intervention group (18 months).  
d. Re-fractures 
Nil data. 
e. Cost-effectiveness 
Nil data. 
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